Eton is seeking FDA approval for its ASN-001 product line, targeting NDA submission and launch.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eton is seeking FDA approval for its ASN-001 product line, targeting NDA submission and launch.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA reviewed an NDA and entered a clinical study agreement for a babesiosis trial involving 60 Degrees Pharmaceuticals.
- BridgeBio announced on August 14, 2026, that it has submitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA).
- The FDA extended the review period for Belite Bio, Inc.'s New Drug Application (NDA).
- InflaRx is seeking discussions with the FDA and collaborating with Staidson BioPharmaceuticals on clinical trials.
- FDA reached agreement on NDA submission plan regarding Ocular Therapeutix.